All News

The BMJ study highlights that young children vaccinated against influenza in October experience the greatest protection, with lower infection rates than those vaccinated earlier.

Members of the Advisory Committee on Immunization Practices (ACIP) voted to restrict the combined measles, mumps, rubella, and varicella (MMRV) vaccine and hepatitis B vaccine for certain age groups.

With this approval, an effective, nonsteroidal treatment option is available for young patients.

Participating in a pharmacist-led secondary intervention clinic helped achieve large reductions in cholesterol levels among patients who have experienced an acute coronary syndrome.

Outpatient use of bispecifics and CAR T-cell therapies in multiple myeloma can expand access.

Teclistamab shows promising results in frontline multiple myeloma treatment, achieving high MRD negativity rates, but safety concerns remain.

Teclistamab and other bispecific antibodies enhance multiple myeloma treatment but significantly increase infection risks, necessitating proactive management strategies.

The latest antibiotic therapies and guidelines offer effective strategies for managing carbapenem-resistant Acinetobacter baumannii infections

Long-term care pharmacists are significant in lessening the vaccine hesitancy hurdle among facility residents.

Elranatamab combined with daratumumab and lenalidomide shows promising results for treating newly diagnosed multiple myeloma, enhancing patient outcomes.

Pharmacists play a critical role in optimizing triazole therapy in preventing and managing invasive fungal infections.

Fluctuations in glycemic delta, a specific measurement of glucose levels, is an indicator of worsened myocardial infarction outcomes, including greater reductions in left ventricular ejection fraction.

The extensive selection of OTC products for GI problems can be challenging for patients to navigate.

An expert discusses the benefits of anti-CD38 quadruplet regimens for elderly multiple myeloma patients.

An expert discusses CAR T therapy's potential in treating relapsed multiple myeloma, highlighting long-term remissions and access challenges.

West Coast states unite to enhance vaccine access and guidance for respiratory viruses, prioritizing public health and safety ahead of the 2025-2026 season.

An expert discusses the promising results of elranatamab as a consolidative therapy for relapsed/refractory multiple myeloma, enhancing patient outcomes.

Anti-Amyloid Antibody Treatments, Subcutaneous Formulations, and Improved Symptom Relief Are Offering New Hope for Patients

Enrollment in the Supplemental Nutrition Assistance Program or another food assistance program could help ameliorate food insecurity that contributes to long COVID.

Additionally, the FDA granted a provisional interchangeability designation to both biosimilars.

NCCN updated its small-cell lung cancer guidelines, introducing lurbinectedin for maintenance therapy and removing the chemotherapy-free interval for better treatment strategies.

Cemiplimab was also superior in improving progression-free survival, objective response rate, and duration of response in patients with non–small cell lung cancer (NSCLC).

Travelers face rising infectious disease risks, including measles, chikungunya, chagas disease, and others.

This study demonstrates the feasibility and impact of a pharmacist-led direct challenge approach to penicillin allergy delabeling in a community hospital setting.

The 2025 International Myeloma Society Annual Meeting unveils crucial updates to IMWG guidelines, enhancing response assessment and treatment strategies for multiple myeloma.

A recent study highlights the AOV dual-chamber system as a faster, safer option for RSV vaccine reconstitution, enhancing efficiency for health care providers.

Misinformation is fueling parental fears and a concerning drop in childhood vaccines.

Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.